IKZF1 and cancer: Using the upper IQR values measured in non-neoplastic tissues as positivity thresholds, hypermethylation of BCAT1 and IKZF1 was observed in 82/91 (90.1%) and 75/91 (82.4%) of cancers, respectively, with 86/91 (94.5%) having elevated levels for either marker.